<div id="readability-page-1"><p>Maximus, Inc. (NYSE:MMS - Free Report) - Equities research analysts at Zacks Research issued their FY2028 earnings per share (EPS) estimates for shares of Maximus in a report issued on Thursday, December 11th. Zacks Research analyst Team anticipates that the health services provider will earn $8.95 per share for the year. Zacks Research currently has a &#34;Hold&#34; rating on the stock. The consensus estimate for Maximus' current full-year earnings is $6.15 per share.</p><p>Maximus (NYSE:MMS - Get Free Report) last released its earnings results on Thursday, November 20th. The health services provider reported $1.62 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.63 by ($0.01). The business had revenue of $1.32 billion during the quarter, compared to the consensus estimate of $1.34 billion. Maximus had a net margin of 5.87% and a return on equity of 25.23%. The business's revenue was up .2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.46 EPS. Maximus has set its FY 2026 guidance at 7.950-8.250 EPS. </p><p>Separately, Weiss Ratings  restated a &#34;buy (b-)&#34; rating on shares of Maximus in a research report on Monday, December 8th. Two analysts have rated the stock with a Buy rating and one  has issued  a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $90.00.</p><p><b>Read Our Latest Research Report on MMS</b></p><h2>Maximus Trading Down 0.8%</h2><p>Shares of Maximus stock opened at $84.33 on Monday. The firm's 50 day moving average is $84.72 and its 200 day moving average is $80.79. The firm has a market capitalization of $4.59 billion, a PE ratio of 15.17 and a beta of 0.56. Maximus has a 1 year low of $63.77 and a 1 year high of $92.50. The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 0.77. </p><h2>Institutional Trading of Maximus</h2><p>Several institutional investors have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP lifted its position in shares of  Maximus by 2.0% in the 3rd quarter. Dimensional Fund Advisors LP now owns 1,869,573 shares of the health services provider's stock worth $170,812,000 after purchasing an additional 36,989 shares during the period.  Fuller &amp; Thaler Asset Management Inc. lifted its holdings in  Maximus by 40.0% in the first quarter. Fuller &amp; Thaler Asset Management Inc. now owns 1,729,305 shares of the health services provider's stock valued at $117,921,000 after buying an additional 494,372 shares during the period.  AQR Capital Management LLC boosted its position in  Maximus by 177.2% during the first quarter. AQR Capital Management LLC now owns 1,173,329 shares of the health services provider's stock valued at $79,341,000 after acquiring an additional 750,031 shares during the last quarter.  Boston Partners grew its holdings in  Maximus by 47.0% during the 3rd quarter. Boston Partners now owns 966,139 shares of the health services provider's stock worth $88,236,000 after acquiring an additional 308,892 shares during the period.  Finally, Reinhart Partners LLC. raised its position in shares of  Maximus by 0.8% in the 3rd quarter. Reinhart Partners LLC. now owns 921,578 shares of the health services provider's stock worth $84,206,000 after acquiring an additional 7,722 shares in the last quarter. 97.21% of the stock is currently owned by institutional investors. </p><h2>Insider Buying and Selling</h2><p>In other Maximus news, insider Michelle F. Link sold 4,039 shares of the business's stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $86.84, for a total transaction of $350,746.76. Following the sale, the insider directly owned 19,542 shares of the company's stock, valued at $1,697,027.28. The trade was a 17.13% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.60% of the stock is currently owned by corporate insiders. </p><h2>Maximus Dividend Announcement</h2><p>The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 1st. Investors of record on Friday, November 14th were issued a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date was Friday, November 14th. Maximus's dividend payout ratio (DPR) is 21.58%. </p><h2>Maximus Company Profile</h2> (Get Free Report)<p>Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.</p><h2>Featured Stories</h2><ul><li>Five stocks we like better than Maximus</li><li>How to start investing in penny stocks</li><li>Dave &amp; Buster’s Reversal Is in PLAY After Double-Bottom Breakout</li><li>3 Grocery Stocks That Can Help Take a Bite Out of Inflation </li><li>3 Finance Stocks to Buy on Rising 10-Year Treasury Rates</li><li>Asset Allocation Strategies in Volatile Markets</li><li>Disney's $1 Billion Deal Brings Its Magic to OpenAI</li></ul> <p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="325" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsEstimatesChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1NUw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Maximus Right Now?</h2><p>Before you consider Maximus, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.</p><p>While Maximus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Zacks Research forecasts Maximus' FY2028 EPS at $8.95, maintaining a 'Hold' rating. Current full-year EPS is $6.15. Maximus reported Q4 EPS of $1.62, slightly missing estimates. The company has a 'Moderate Buy' consensus with a $90 target price. Institutional investors hold 97.21% of shares. Maximus recently paid a $0.30 quarterly dividend. Insider Michelle F. Link sold shares, reducing her position by 17.13%. The company provides government services in the U.S. and internationally.</p>

Zacks Research Forecasts Maximus' FY2028 Earnings (NYSE:MMS)